Literature DB >> 8878030

Three conserved consensus sequences identify the NAD-binding site of ADP-ribosylating enzymes, expressed by eukaryotes, bacteria and T-even bacteriophages.

M Domenighini1, R Rappuoli.   

Abstract

It has been previously reported that the three-dimensional structures of the NAD-binding and catalytic site of bacterial toxins with ADP-ribosylating activity are superimposable, and that the key amino acids for the enzymatic activity are conserved. The model includes an NAD-binding and catalytic site formed by an alpha-helix bent over a beta-strand, surrounded by two beta-strands bearing a Glu and a His, or Arg, that are required for catalysis. We show here that the model can be extended to comprise all proteins with ADP-ribosylating activity known to date, including all eukaryotic mono- and poly-ADP-ribosyltransferases, the bacterial ADP-ribosylating enzymes which do not have toxic activity, and the analogous enzymes encoded by T-even bacteriophages. We show that, in addition to the common Glu and Arg/His amino acids previously identified, the conserved motifs can be extended as follows: (i) the Arg/His motif is usually arom-His/Arg (where 'arom' is an aromatic residue); (ii) in the sequences of the CT group the beta-strand forming part of the 'scaffold' of the catalytic cavity has an arom-ph-Ser-Thr-Ser-ph consensus (where 'ph' represents a hydrophobic residue); and (iii) the motif centered in the key glutamic residue is Glu/Gin-X-Glu; while (iv) in the sequences of the DT group the NAD-binding motif is Tyr-X10-Tyr. We believe that the model proposed not only accounts for all ADP-ribosylating proteins known to date, but it is likely to fit other enzymes (currently being analysed) which possess such an activity.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8878030     DOI: 10.1046/j.1365-2958.1996.321396.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  45 in total

1.  Characterization of the enzymatic component of Clostridium perfringens iota-toxin.

Authors:  M Nagahama; Y Sakaguchi; K Kobayashi; S Ochi; J Sakurai
Journal:  J Bacteriol       Date:  2000-04       Impact factor: 3.490

2.  Binding component of Clostridium perfringens iota-toxin induces endocytosis in Vero cells.

Authors:  Masahiro Nagahama; Koichi Nagayasu; Keiko Kobayashi; Jun Sakurai
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

3.  Modification of a mammalian cell protein in the presence of [32P-adenylate]NAD: evidence for ADP ribosylation activity associated with Helicobacter pylori.

Authors:  Carlos W Nossa; Steven R Blanke
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

4.  Binding and internalization of Clostridium perfringens iota-toxin in lipid rafts.

Authors:  Masahiro Nagahama; Akiwo Yamaguchi; Tohko Hagiyama; Noriko Ohkubo; Keiko Kobayashi; Jun Sakurai
Journal:  Infect Immun       Date:  2004-06       Impact factor: 3.441

5.  SpyA, a C3-like ADP-ribosyltransferase, contributes to virulence in a mouse subcutaneous model of Streptococcus pyogenes infection.

Authors:  Jessica S Hoff; Mark DeWald; Steve L Moseley; Carleen M Collins; Jovanka M Voyich
Journal:  Infect Immun       Date:  2011-03-21       Impact factor: 3.441

6.  Purification and molecular cloning of a DNA ADP-ribosylating protein, CARP-1, from the edible clam Meretrix lamarckii.

Authors:  Tsuyoshi Nakano; Yuko Matsushima-Hibiya; Masafumi Yamamoto; Shigeki Enomoto; Yasuko Matsumoto; Yukari Totsuka; Masahiko Watanabe; Takashi Sugimura; Keiji Wakabayashi
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-31       Impact factor: 11.205

Review 7.  Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions.

Authors:  D D'Amours; S Desnoyers; I D'Silva; G G Poirier
Journal:  Biochem J       Date:  1999-09-01       Impact factor: 3.857

8.  Human alpha-defensins neutralize toxins of the mono-ADP-ribosyltransferase family.

Authors:  Chun Kim; Zoya Slavinskaya; A Rod Merrill; Stefan H E Kaufmann
Journal:  Biochem J       Date:  2006-10-15       Impact factor: 3.857

9.  ADP-ribosylation as an intermediate step in inactivation of rifampin by a mycobacterial gene.

Authors:  S Quan; T Imai; Y Mikami; K Yazawa; E R Dabbs; N Morisaki; S Iwasaki; Y Hashimoto; K Furihata
Journal:  Antimicrob Agents Chemother       Date:  1999-01       Impact factor: 5.191

10.  ModA and ModB, two ADP-ribosyltransferases encoded by bacteriophage T4: catalytic properties and mutation analysis.

Authors:  Bernd Tiemann; Reinhard Depping; Egle Gineikiene; Laura Kaliniene; Rimas Nivinskas; Wolfgang Rüger
Journal:  J Bacteriol       Date:  2004-11       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.